Allelic deletions of Rb and L-myc in urine sediments from patients with bladder tumors or carcinoma in situ

Oncology Reports

Volumn 9, Issue 3, 2002, Pages 551-555

  Primdahl, Hanne ^a   Von Der Maase, Hans ^a   Christensen, Mariann ^a   Wolf, Hans ^a   Ørntoft, Torben Falck ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bladder cancer; Carcinoma in situ; L myc; Rb; Urine

Indexed keywords

MICROSATELLITE DNA; MYC PROTEIN; RETINOBLASTOMA PROTEIN;

ALLELE; ARTICLE; BLADDER TUMOR; CARCINOMA IN SITU; GENETICS; HOMOZYGOTE; HUMAN; MALE; METABOLISM; ONCOGENE MYC; URINE;

ALLELES; CARCINOMA IN SITU; GENES, MYC; HOMOZYGOTE; HUMANS; MALE; MICROSATELLITE REPEATS; PROTO-ONCOGENE PROTEINS C-MYC; RETINOBLASTOMA PROTEIN; URINARY BLADDER NEOPLASMS;

EID: 0036581213     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.3.551     Document Type: Article

References (21)

1. Primdahl H, von der Maase H, Christensen M, Wolf H and Orntoft TF: Allelic deletions of cell growth regulators during progression of bladder cancer. Cancer Res 60: 6623-6629, 2000.
2. Mao L, Schoenberg MP, Scicchitano M, Erozan YS, Merlo A, Schwab D and Sidransky D: Molecular detection of primary bladder cancer by microsatellite analysis. Science 271: 659-662, 1996. (Pubitemid 26052913)
3. Christensen M, Wolf H and Orntoft TF: Microsatellite alterations in urinary sediments from patients with cystitis and bladder cancer. Int J Cancer 85: 614-617, 2000. (Pubitemid 30080471)
4. Sourvinos G, Kazanis I, Delakas D, Cranidis A and Spandidos DA: Genetic detection of bladder cancer by microsatellite analysis of p16, RB1 and p53 tumor suppressor genes. J Urol 165:249-252, 2001.
5. Steiner G, Schoenberg MP, Linn JF, Mao L and Sidransky D: Detection of bladder cancer recurrence by microsatellite analysis of urine. Nat Med 3: 621-624, 1997. (Pubitemid 27264970)
6. Zhang J, Fan Z, Gao Y, Xiao Z, Li C, An Q and Cheng S: Detecting bladder cancer in the chinese by microsatellite analysis: ethnic and etiologic considerations. J Natl Cancer Inst 93: 45-50, 2001. (Pubitemid 32060889)
7. Linn JF, Lango M, Halachmi S, Schoenberg MP and Sidransky D: Microsatellite analysis and telomerase activity in archived tissue and urine samples of bladder cancer patients. Int J Cancer 74: 625-629, 1997. (Pubitemid 28037506)
8. Schneider A, Borgnat S, Lang H, Regine O, Lindner V, Kassem M, Saussine C, Oudet P, Jacqmin D and Gaub MP: Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer. Cancer Res 60: 4617-4622, 2000. (Pubitemid 32103648)
9. Mourah S, Cussenot O, Vimont V, Desgrandchamps F, Teillac P, Cochant-Priollet B, Le Duc A, Fiet J and Soliman H: Assessment of microsatellite instability in urine in the detection of transitional-cell carcinoma of the bladder. Int J Cancer 79: 629-633, 1998. (Pubitemid 28549476)
10. Presti-JCJ, Reuter VE, Galan T, Fair WR and Cordon CC: Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res 51: 5405-5409, 1991.
11. Cote RJ, Dunn MD, Chatterjee SJ, Stein JP, Shi SR, Tran QC, Hu SX, Xu HJ, Groshen S, Taylor CR, Skinner DG and Benedict WF: Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res 58: 1090-1094, 1998. (Pubitemid 28183188)
12. Cordon CC, Zhang ZF, Dalbagni G, Drobnjak M, Charytonowicz E, Hu SX, Xu HJ, Reuter VE and Benedict WF: Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors. Cancer Res 57: 1217-1221, 1997. (Pubitemid 27152539)
13. Agarwal ML, Taylor WR, Chernov MV, Chernova OB and Stark GR: The p53 network. J Biol Chem 273: 1-4, 1998. (Pubitemid 28042164)
14. Yu K, Ravera CP, Chen YN and McMahon G: Regulation of Myc-dependent apoptosis by p53, c-Jun N-terminal kinases/stress-activated protein kinases and Mdm-2. Cell Growth Differ 8: 731-742, 1997. (Pubitemid 27287804)
15. Nesbit CE, Grove LE, Yin X and Prochownik EV: Differential apoptotic behaviors of c-myc, N-myc and L-myc oncoproteins. Cell Growth Differ 9: 731-741, 1998. (Pubitemid 28425870)
16. Ejarque MJ, Vicente M, Bernues M, Oliver A, Vicente J, Capella G, Lluis F and Chechile G: Restriction fragment length polymorphism of the L-myc gene is not a prognostic factor in bladder cancer patients. Br J Cancer 79: 1855-1858, 1999. (Pubitemid 29132315)
17. Wolf H, Kakizoe T, Smith PH, Brosman SA, Okajima E, Rubben H and Utz DC: Bladder tumors. Treated natural history. Prog Clin Biol Res 221: 223-255, 1986.
18. Utz DC, Farrow GM, Rife CC, Segura JW and Zincke H: Carcinoma in situ of the bladder. Cancer 45: 1842-1848, 1980. (Pubitemid 10153633)
19. Herr HW: Carcinoma in situ of the bladder. Semin Urol Oncol 1: 15-22, 1983.
20. Bergkvist A, Ljungqvist A and Moberger G: Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 130: 371-378, 1965.
21. Brown FM: Urine cytology. Is it still the gold standard for screening? Urol Clin North Am 27: 25-37, 2000.